News for Healthier Living

First-in-Class Small Molecule Inhibitor Designed with AI Support Shows Promise Against Pancreatic Cancer in Preclinical Studies

Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1 protein that helps different types of cancer, including pancreatic cancer, to grow and resist treatment.

August 5, 2026


August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026